Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration

Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration

Introduction: To assess whether switching from Ranibizumab to Aflibercept conferred benefit in visual acuity (VA) and central macular thickness (CMT) in patients with wet age-related macular degeneration (AMD). Methods: Mean change in VA and CMT was assessed in wet AMD patients 6 months prior and 6...

Full description

Saved in:
Bibliographic Details
Main Authors: Bhagya Weerasinghe, Chandni Gupta, Yasmin Levene, Jai Shankar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Delhi Journal of Ophthalmology
Subjects:
wet amd
ranibizumab
aflibercept
switch
outcome
Online Access:https://journals.lww.com/10.7869/djo.625
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items